Used primarily in research settings, this compound is designed to target and degrade IRAK4 proteins, which play a role in inflammatory and oncogenic signaling pathways. Its application is significant in studying diseases where IRAK4 is implicated, such as certain cancers and autoimmune disorders. By degrading IRAK4, it helps in understanding the protein's function and in exploring potential therapeutic strategies for conditions driven by IRAK4 activity. This makes it a valuable tool in the development of targeted therapies, particularly in the context of precision medicine.